Havens Advisors LLC raised its position in Monsanto Co. (NYSE:MON) by 77.1% during the third quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 65,000 shares of the company’s stock after buying an additional 28,300 shares during the period. Monsanto comprises about 5.2% of Havens Advisors LLC’s investment portfolio, making the stock its 8th largest position. Havens Advisors LLC’s holdings in Monsanto were worth $6,643,000 as of its most recent filing with the SEC.

A number of other institutional investors have also bought and sold shares of MON. First Western Capital Management Co raised its position in Monsanto by 1.4% in the second quarter. First Western Capital Management Co now owns 18,295 shares of the company’s stock valued at $1,892,000 after buying an additional 244 shares during the last quarter. Atria Investments LLC bought a new stake in Monsanto during the second quarter worth about $429,000. Franklin Street Advisors Inc. NC bought a new stake in Monsanto during the second quarter worth about $5,223,000. Gulf International Bank UK Ltd increased its stake in Monsanto by 1.5% in the second quarter. Gulf International Bank UK Ltd now owns 131,974 shares of the company’s stock worth $13,647,000 after buying an additional 2,000 shares during the period. Finally, TT International increased its stake in Monsanto by 5.2% in the second quarter. TT International now owns 28,731 shares of the company’s stock worth $2,971,000 after buying an additional 1,408 shares during the period. Hedge funds and other institutional investors own 73.94% of the company’s stock.

Institutional Ownership by Quarter for Monsanto (NYSE:MON)

Shares of Monsanto Co. (NYSE:MON) traded down 0.52% during trading on Monday, hitting $102.03. 1,628,470 shares of the stock were exchanged. Monsanto Co. has a 12-month low of $83.73 and a 12-month high of $114.26. The stock has a 50-day moving average of $101.01 and a 200 day moving average of $103.96. The stock has a market cap of $44.69 billion, a P/E ratio of 34.15 and a beta of 1.01.

Monsanto (NYSE:MON) last issued its quarterly earnings results on Wednesday, October 5th. The company reported $0.07 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($0.02) by $0.09. The business earned $2.56 billion during the quarter, compared to analyst estimates of $2.38 billion. Monsanto had a net margin of 9.89% and a return on equity of 46.07%. The business’s revenue was up 8.8% compared to the same quarter last year. During the same quarter in the previous year, the firm earned ($0.19) earnings per share. Equities analysts predict that Monsanto Co. will post $4.73 earnings per share for the current fiscal year.

TRADEMARK VIOLATION NOTICE: This piece of content was reported by The Cerbat Gem and is owned by of The Cerbat Gem. If you are viewing this piece of content on another publication, it was copied illegally and republished in violation of US & international copyright and trademark laws. The correct version of this piece of content can be viewed at https://www.thecerbatgem.com/2016/11/28/monsanto-co-mon-stake-boosted-by-havens-advisors-llc.html.

Several equities research analysts recently weighed in on MON shares. Monness Crespi & Hardt raised shares of Monsanto from a “neutral” rating to a “buy” rating and upped their target price for the stock from $106.93 to $130.00 in a research note on Monday, August 8th. Deutsche Bank AG upped their target price on shares of Monsanto from $118.00 to $128.00 and gave the stock a “buy” rating in a research note on Thursday, September 15th. Jefferies Group reaffirmed a “buy” rating on shares of Monsanto in a research note on Tuesday, September 6th. BMO Capital Markets set a $128.00 target price on shares of Monsanto and gave the stock a “buy” rating in a research note on Thursday, September 15th. Finally, Piper Jaffray Cos. set a $128.00 target price on shares of Monsanto and gave the stock a “buy” rating in a research note on Thursday, September 15th. Three analysts have rated the stock with a sell rating, eight have assigned a hold rating and fifteen have given a buy rating to the company’s stock. The stock has an average rating of “Hold” and a consensus price target of $114.06.

In other Monsanto news, EVP Steven Mizell sold 310 shares of Monsanto stock in a transaction on Monday, October 10th. The shares were sold at an average price of $103.09, for a total value of $31,957.90. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Also, Director Charles S. Mcmillan acquired 3,500 shares of the firm’s stock in a transaction on Monday, October 10th. The stock was acquired at an average cost of $103.23 per share, with a total value of $361,305.00. Following the acquisition, the director now owns 64,009 shares of the company’s stock, valued at $6,607,649.07. The disclosure for this purchase can be found here. 0.88% of the stock is currently owned by company insiders.

About Monsanto

Monsanto Company (Monsanto), along with its subsidiaries, is a provider of agricultural products for farmers. The Company provides seeds, biotechnology trait products, herbicides and precision agriculture tools to farmers. The Company operates through two segments: Seeds and Genomics, and Agricultural Productivity.

5 Day Chart for NYSE:MON

Receive News & Stock Ratings for Monsanto Co. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Monsanto Co. and related stocks with our FREE daily email newsletter.